Acorda Therapeutics Inc.

News - Acorda Therapeutics Inc.

Multiple Sclerosis Association of America and National Disability Institute Launch a Four-Part Webinar Series on Financial Wellness for the Multiple Sclerosis Community

2011-09-14 11:03:00

CHERRY HILL, N.J., Sept.

BioMed Realty Trust Reports Second Quarter 2011 Financial Results

2011-08-03 15:42:00

SAN DIEGO, Aug. 3, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc.

Acorda Therapeutics Presents Additional Data From Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in Multiple Sclerosis

2008-09-20 09:00:14

Acorda Therapeutics, Inc.

Acorda Therapeutics' Preclinical Pipeline Named One of the 10 Most Promising Neuroscience Projects Available for Partnering By Windhover

2008-08-21 09:01:14

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company's preclinical pipeline has been selected by Windhover Information and an independent neuroscience expert as one of the top 10 most interesting neuroscience projects in development available for strategic partnering.

Acorda Therapeutics Announces Positive Data From Second Phase 3 Study of Fampridine-SR on Walking Ability in People With Multiple Sclerosis

2008-06-02 06:00:33

Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced positive results from its second Phase 3 clinical trial of Fampridine-SR (MS-F204) on walking ability in people with multiple sclerosis (MS).

More News (12 articles) »

News - Acorda Therapeutics Inc.

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health